As with any test, the likelihood of the disease being present is different at different concentrations of the test substance (e.g., HCC is more likely if the AFP is 20,000 mg/L than if it is 5 mg/L).

A significant difference in serum alpha-fetoprotein (AFP)-production was observed in HCC's associated with underlying HBV as opposed to those associated with HCV (Table 1). The median level of ...

OPN, a glycoprotein over-expressed in various tumors, has been studied for its potential as an additional HCC biomarker to AFP. Salem et al. documented elevated OPN levels in HCC patients, with 73% ...

Our previous study showed that pre-transplant AFP level and 18 F-FDG standard uptake value (SUV max) were independent risk factors for HCC recurrence fonc.2021.635731. The study also proposed that ...

Objective Serum α-fetoprotein (AFP) is the most commonly used biomarker for screening hepatocellular carcinoma (HCC) but fails to detect about half of the patients. Thus, we investigated if ...

The PBIScore exhibited good performance in detecting HCC and PDAC, with both sensitivity and specificity being around 80% in the validation cohorts. We further established an integrated PBIScore ...

Agence France-Presse (AFP) and Mistral AI have formed a partnership that will provide Mistral's conversational AI assistant, Le Chat, with access to the full range of AFP's text stories.

AFP is a leading global news agency providing fast, comprehensive and verified coverage of the events shaping our world and of the issues affecting our daily lives. Drawing from an unparalleled ...

vs percutaneous transhepatic biliary drainage (PTBD) for cholangiocarcinoma biliary obstruction: An updated systematic review and meta analysis. Baseline characteristics of patients with combined ...

The Armed Forces of the Philippines (AFP) said it is improving its intelligence and cyber defense amid the reported espionage activities in the country. “As part of our efforts to strengthen the ...

Current status of physicians’ perception of HCC conversion/downstaging therapy: A nationwide survey in China. A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination ...